益生菌GKM3对肥胖患者的减重效果评估
Evaluation of the Weight Loss Effect of Probiotic GKM3 in Obese Patients
DOI: 10.12677/hjfns.2025.146095, PDF,   
作者: 王启宪, 李宜蓁, 陈英瑜, 林诗伟, 陈炎炼:葡萄王生技股份有限公司;林静敏:上海葡萄王企业有限公司;林文鑫:中国医药大学药学系;陈劲初*:葡萄王生技股份有限公司;台湾大学食品科技研究所(中国台湾地区);台湾中山大学生技医药研究所(中国台湾地区);中原大学生物科技学系
关键词: 益生菌Lactobacillus plantarum GKM3GLP-1肥胖临床试验体脂肪Probiotic Lactobacillus plantarum GKM3 GLP-1 Obesity Clinical Trials Body Fat
摘要: 益生菌被定义为活体微生物,当以足够的剂量施用时,可赋予宿主健康益处。本研究利用人类结肠类癌细胞株NCI-H716细胞株评估,发现Lactobacillus plantarum GKM3培养上清液可促进其分泌GLP-1蛋白,可能有助于抗肥胖,因此进行评估L. plantarum GKM3能否对肥胖患者产生有益性的效果。28位受试者于每日早、晚餐后各服用一次含L. plantarum GKM3的益生菌胶囊,连续90天,要求受试者每日记录体重变化,每周记录体脂肪变化,并在服用前第1天、第45天以及第90天采集血液,评估服用益生菌前后的血液生化数值变化。结果发现服用L. plantarum GKM3后,受试者于试验结束时体脂率显著下降(p < 0.05),而体重与BMI虽有下降趋势,但未达显著。以BMI将受试者分组后发现,过重组于第45天及第90天均显著降低体重及BMI (p < 0.05),中度肥胖组体脂率于第90天显著下降(p < 0.05)。血脂指标方面,高密度脂蛋白胆固醇(HDL-C)显著上升(p < 0.05),总胆固醇与HDL-C比值亦显著改善。血糖、肝肾功能及甲状腺指数无显著变化。此外观测受试者排便情形,服用L. plantarum GKM3后,确实可明显地改善腹泻情形。综合结果显示,L. plantarum GKM3可促进GLP-1分泌,并对体脂调控、血脂代谢及肠道健康具有正向影响,具有作为辅助体重管理的潜力。
Abstract: Probiotics are defined as live microorganisms that, when administered in adequate amounts, confer health benefits on the host. In this study, the human enteroendocrine cell line NCI-H716 was used to evaluate the effects of Lactobacillus plantarum GKM3, and the results demonstrated that the culture supernatant of L. plantarum GKM3 promoted GLP-1 secretion, suggesting a potential anti-obesity effect. To further investigate, we conducted a human trial in which 28 participants consumed one capsule containing L. plantarum GKM3 after breakfast and dinner daily for 90 consecutive days. Participants were instructed to record their body weight daily, measure body fat once per week, and provide blood samples on Day 1, Day 45, and Day 90 for biochemical analysis. The results showed that after supplementation with L. plantarum GKM3, body fat percentage was significantly reduced at the end of the trial (p < 0.05), whereas reductions in body weight and BMI did not reach statistical significance. Subgroup analysis by BMI revealed that the overweight group exhibited significant reductions in both body weight and BMI on Day 45 and Day 90 (p < 0.05), while the moderately obese group showed a significant reduction in body fat percentage at Day 90 (p < 0.05). Regarding lipid profiles, high-density lipoprotein cholesterol (HDL-C) was significantly increased (p < 0.05), and the total cholesterol-to-HDL-C ratio was significantly improved. No significant changes were observed in blood glucose, liver and kidney function, or thyroid indices. In addition, bowel habit assessments indicated that supplementation with L. plantarum GKM3 markedly reduced the incidence of diarrhea. Taken together, these findings demonstrate that L. plantarum GKM3 promotes GLP-1 secretion and exerts beneficial effects on body fat regulation, lipid metabolism, and gut health, supporting its potential as an adjunct for weight management.
文章引用:王启宪, 李宜蓁, 陈英瑜, 林诗伟, 林静敏, 陈炎炼, 林文鑫, 陈劲初. 益生菌GKM3对肥胖患者的减重效果评估[J]. 食品与营养科学, 2025, 14(6): 863-872. https://doi.org/10.12677/hjfns.2025.146095

参考文献

[1] World Health Organization (2024) Obesity and Overweight. World Health Organization.
https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
[2] Yadav, H., Lee, J., Lloyd, J., Walter, P. and Rane, S.G. (2013) Beneficial Metabolic Effects of a Probiotic via Butyrate-Induced GLP-1 Hormone Secretion. Journal of Biological Chemistry, 288, 25088-25097. [Google Scholar] [CrossRef] [PubMed]
[3] Jalleh, R.J., Rayner, C.K., Jones, K.L. and Horowitz, M. (2022) Glucagon‐Like Peptide‐1 Receptor Agonists, Weight Loss, and Gastric Emptying: Have I Gut News for You. Obesity, 30, 1533-1534. [Google Scholar] [CrossRef] [PubMed]
[4] Tsai, Y.S., Lin, X.B., Lin, S.W., Chen, Y.L., Hsu, C.L. and Chen, C.C. (2025) Impact of Probiotic Lactobacillus plantarum GKM3 on Gastrointestinal Health in Overweight and Obese Individuals: A Randomized Clinical Trial. Clinical Nutrition ESPEN, 68, 283-291. [Google Scholar] [CrossRef] [PubMed]
[5] Sohn, M., Jung, H., Lee, W.S., Kim, T.H. and Lim, S. (2023) Effect of Lactobacillus plantarum LMT1-48 on Body Fat in Overweight Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes & Metabolism Journal, 47, 92-103. [Google Scholar] [CrossRef] [PubMed]
[6] Analysis of Organic Acid in Aqueous Samples, 5989-1265EN.
[7] Kim, A.-R., Jeon, S.-G., Park, S.-J., Hong, H., Kim, B. K., Kim, H.-R., Hong, C.-P. and Yang, B.-G. (2025) Alleviation of Adipose Tissue Inflammation and Obesity Suppression by a Probiotic Strain That Induces GLP-1 Secretion. Microorganisms, 13, Article No. 1211. [Google Scholar] [CrossRef] [PubMed]
[8] 孙至柔. 乳酸菌补充剂对高脂饮食诱导肥胖大鼠之抗肥胖作用及其分子机制探讨[D]: [硕士学位论文]. 台中: 中山医学大学, 2017.
[9] Clark, J.E. and Welch, S. (2021) Comparing Effectiveness of Fat Burners and Thermogenic Supplements to Diet and Exercise for Weight Loss and Cardiometabolic Health: Systematic Review and Meta-Analysis. Nutrition and Health, 27, 445-459. [Google Scholar] [CrossRef] [PubMed]
[10] Pavlović, N., Stankov, K. and Mikov, M. (2012) Probiotics—Interactions with Bile Acids and Impact on Cholesterol Metabolism. Applied Biochemistry and Biotechnology, 168, 1880-1895. [Google Scholar] [CrossRef] [PubMed]
[11] Han, K., Wang, X., Wang, Y., Niu, X., Xiang, J., Ru, N., et al. (2024) Prevalence of Chronic Diarrhea and Its Association with Obesity in a Chinese Community-Based Population. Chinese Medical Journal, 138, 1587-1594. [Google Scholar] [CrossRef] [PubMed]
[12] Singh, P., Mitsuhashi, S., Ballou, S., Rangan, V., Sommers, T., Cheng, V., et al. (2018) Demographic and Dietary Associations of Chronic Diarrhea in a Representative Sample of Adults in the United States. American Journal of Gastroenterology, 113, 593-600. [Google Scholar] [CrossRef] [PubMed]
[13] Delgado-Aros, S., Locke, G.R., Camilleri, M., Talley, N.J., Fett, S., Zinsmeister, A.R., et al. (2004) Obesity Is Associated with Increased Risk of Gastrointestinal Symptoms: A Population-Based Study. American Journal of Gastroenterology, 99, 1801-1806. [Google Scholar] [CrossRef] [PubMed]
[14] Zhuang, Y., Li, L., Sun, J., Zhang, Y. and Dai, F. (2025) Association of Body Roundness Index with Chronic Diarrhea and Constipation, NHANES 2005-2010. Journal of Health, Population and Nutrition, 44, Article No. 50. [Google Scholar] [CrossRef] [PubMed]
[15] Ballou, S., Singh, P., Rangan, V., Iturrino, J., Nee, J. and Lembo, A. (2019) Obesity Is Associated with Significantly Increased Risk for Diarrhoea after Controlling for Demographic, Dietary and Medical Factors: A Cross‐Sectional Analysis of the 2009‐2010 National Health and Nutrition Examination Survey. Alimentary Pharmacology & Therapeutics, 50, 1019-1024. [Google Scholar] [CrossRef] [PubMed]
[16] Yang, B., Yue, Y., Chen, Y., Ding, M., Li, B., Wang, L., et al. (2021) Lactobacillus plantarum CCFM1143 Alleviates Chronic Diarrhea via Inflammation Regulation and Gut Microbiota Modulation: A Double-Blind, Randomized, Placebo-Controlled Study. Frontiers in Immunology, 12, Article ID: 746585. [Google Scholar] [CrossRef] [PubMed]